tiprankstipranks
Trending News
More News >
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
PremiumRatingsBuy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
27d ago
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
Premium
Company Announcements
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
29d ago
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
Premium
Ratings
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
29d ago
Iterum Therapeutics prices 5.56M shares at 90c in registered direct offering
PremiumThe FlyIterum Therapeutics prices 5.56M shares at 90c in registered direct offering
1M ago
Iterum Therapeutics Appoints New Board Members
Premium
Company Announcements
Iterum Therapeutics Appoints New Board Members
3M ago
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA Approval
Premium
Company Announcements
Iterum Therapeutics Faces Commercialization Challenges for ORLYNVAH™ Despite FDA Approval
4M ago
Iterum Therapeutics reports Q4 non-GAAP EPS (12c) vs. (81c) last year
PremiumThe FlyIterum Therapeutics reports Q4 non-GAAP EPS (12c) vs. (81c) last year
4M ago
Iterum Therapeutics sees cash runway into 2H25
Premium
The Fly
Iterum Therapeutics sees cash runway into 2H25
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100